JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MUELLER, R. A.
Right arrow Articles by AXELROD, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MUELLER, R. A.
Right arrow Articles by AXELROD, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 1, 74-79, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


INCREASE IN TYROSINE HYDROXYLASE ACTIVITY AFTER RESERPINE ADMINISTRATION

R. A. MUELLER 1, H. THOENEN 1, and J. AXELROD 1

1 Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland

After the administration of reserpine, the in vitro tyrosine hydroxylase activity increases in rat, guinea-pig, mouse and rabbit adrenal gland, in rat superior cervical ganglia and in rabbit brainstem. The increase in enzyme activity of rat ganglia and adrenals was dose-dependent up to 5 mg/kg and persisted for at least four days after reserpine was given. Repeated doses of reserpine produced an even greater increase in tyrosine hydroxylase activity. The increase in enzyme activity did not appear to be due to the appearance of an activator or loss of an inhibitor. The Km for tyrosine and pteridine co-factor with enzyme prepared from reserpine-treated animals was not significantly different from that of control animals; however, a significant increase in Vmax for both substrate and co-factor was observed. These results suggest that prolonged periods of drug-induced sympathoadrenal hyperactivity can increase the amount of tyrosine hydroxylase in adrenergic areas of the central and peripheral nervous systems.

Submitted on February 17, 1969
Accepted on May 27, 1969




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
X. Chen, L. Xu, P. Radcliffe, B. Sun, and A. W. Tank
Activation of Tyrosine Hydroxylase mRNA Translation by cAMP in Midbrain Dopaminergic Neurons
Mol. Pharmacol., June 1, 2008; 73(6): 1816 - 1828.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Viguie, J. Thibault, J.-C. Thiery, Y. Tillet, and B. Malpaux
Characterization of the Short Day-Induced Decrease in Median Eminence Tyrosine Hydroxylase Activity in the Ewe: Temporal Relationship to the Changes in Luteinizing Hormone and Prolactin Secretion and Short Day-Like Effect of Melatonin
Endocrinology, January 1, 1997; 138(1): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tinti, B. Conti, J. F. Cubells, K.-S. Kim, H. Baker, and T. H. Joh
Inducible cAMP Early Repressor Can Modulate Tyrosine Hydroxylase Gene Expression after Stimulation of cAMP Synthesis
J. Biol. Chem., October 11, 1996; 271(41): 25375 - 25381.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Kumai, M. Tanaka, M. Watanabe, H. Nakura, and S. Kobayashi
Influence of Androgen on Tyrosine Hydroxylase mRNA in Adrenal Medulla of Spontaneously Hypertensive Rats
Hypertension, July 1, 1995; 26(1): 208 - 212.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Iwai, K. Hanai, I. Tooyama, Y. Kitamura, and M. Kinoshita
Regulation of Neuronal Nitric Oxide Synthase in Rat Adrenal Medulla
Hypertension, March 1, 1995; 25(3): 431 - 436.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
E Gizang-Ginsberg and E B Ziff
Nerve growth factor regulates tyrosine hydroxylase gene transcription through a nucleoprotein complex that contains c-Fos.
Genes & Dev., April 1, 1990; 4(4): 477 - 491.
[Abstract] [PDF]


Home page
ScienceHome page
I. Black, J. Adler, C. Dreyfus, W. Friedman, E. LaGamma, and A. Roach
Biochemistry of information storage in the nervous system
Science, June 5, 1987; 236(4806): 1263 - 1268.
[Abstract] [PDF]


Home page
ScienceHome page
J Axelrod and T. Reisine
Stress hormones: their interaction and regulation
Science, May 4, 1984; 224(4648): 452 - 459.
[Abstract] [PDF]


Home page
ScienceHome page
G. Jonakait, M. Bohn, and I. Black
Maternal glucocorticoid hormones influence neurotransmitter phenotypic expression in embryos
Science, October 31, 1980; 210(4469): 551 - 553.
[Abstract] [PDF]


Home page
ScienceHome page
I. Ulus and R. Wurtman
Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain
Science, December 3, 1976; 194(4269): 1060 - 1061.
[Abstract] [PDF]


Home page
ScienceHome page
W. Emlen, D. S. Segal, and A. J. Mandell
Thyroid State: Effects on Pre-and Postsynaptic Central Noradrenergic Mechanisms
Science, January 7, 1972; 175(4017): 79 - 82.
[Abstract] [PDF]


Home page
ScienceHome page
D. S. Segal, J. L. Sullivan III, R. T. Kuczenski, and A. J. Mandell
Effects of Long-Term Reserpine Treatment on Brain Tyrosine Hydroxylase and Behavioral Activity
Science, August 27, 1971; 173(3999): 847 - 849.
[Abstract] [PDF]


Home page
ScienceHome page
J. Axelrod
Noradrenaline: Fate and Control of Its Biosynthesis
Science, August 13, 1971; 173(3997): 598 - 606.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.